Increased expression of IGFBP2 caused by loss of miR-126 was found to promote breast cancer cell metastasis by recruitment of endothelial cells to the cancer site through up-regulating the insulin growth factor 1 receptor (IGF1R) signaling pathway [12]. Here, IGFBP2 is linked to breast carcinoma.